Skip to main content
Premium Trial:

Request an Annual Quote

Johns Hopkins, Imec to Develop Lab-on-a-Chip Technology

NEW YORK (GenomeWeb News) – The Johns Hopkins University and Imec today announced a collaboration to "expand healthcare applications" for silicon nanotechnology.

Specifically, the partners aim to develop new lab-on-a-chip concepts based on Imec's nano-electronic capabilities. Such chips would be loaded with patient samples of blood, saliva, or urine for analysis on smartphones, tablets, or computers. The technology, they said, would bring diagnostic testing outside of the laboratory, "making diagnostic testing faster and easier for applications such as disease monitoring and management, disease surveillance, rural healthcare, and clinical trials."

The technology, would be "the healthcare equivalent of transforming a rotary telephone into the iPhone," Drew Pardoll, a professor of oncology at JHU, added in a statement.

Pardoll will lead the advisory board for the Johns Hopkins-Imec collaboration, which also will seek to extend silicon nanotechnology applications into other areas of medicine.

Financial and other terms of the deal were not disclosed.

"This relationship with Johns Hopkins is an important step toward creating a powerful cross-disciplinary ecosystem with consumer electronics and mobile companies, medical device manufacturers, research centers, and the broader biopharma and semiconductor industries, to create the combined expertise required to address huge healthcare challenges that lie ahead," Luc Van den hove, CEO of Imec, said in a statement. "Only through close collaboration will we be able to develop technology solutions for more accurate, reliable, and low-cost diagnostics that pave the way to better, predictive, and preventive home-based personal healthcare."

Belgium-based Imec specializes in nano-electronic research.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.